Azactam Injection, Powder, For Solution
Product Images NDC 50090-7494

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Azactam (NDC 50090-7494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aztreonam Chemical Structure (Aztreonam Struct)

Chemical structure of aztreonam, depicting its molecular arrangement including functional groups such as sulfonic acid, lactam ring, and thiazole moiety, consistent with the active ingredient in AZACTAM injection powder for solution.*

FDA Label Image

Figure 1 (Figure 1)

A pharmacokinetic curve showing Aztreonam serum concentration (mcg/ml) over 8 hours after administration. The graph compares concentrations for intravenous (IV) and intramuscular (IM) routes with doses of 2 g, 1 g, and 500 mg, illustrating the decline in serum levels over time for each dose and route.*

FDA Label Image

Label Image (Lbl500907494)

AZACTAM (aztreonam) injection powder for solution, 1 gram, labeled for human prescription use. The label indicates the product is stored in the original package at 68 to 77 degrees Fahrenheit, avoiding excessive heat, and contains 1 box with 10 vials. The labeler is A-S Medication Solutions with product NDC 50090-7494.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.